SPDYE2L activators belong to a category of chemical agents that interact with the SPDYE2L protein, which is a part of the broader family of proteins involved in the regulation of cell cycle and division. The acronym SPDYE2L stands for "Speedy/RINGO cell cycle regulator family member E2-like," indicating its functional relationship to the Speedy/RINGO proteins, which are known to have roles in cell cycle progression. SPDYE2L activators are compounds that specifically target this protein, influencing its activity. The exact biochemical mechanism through which these activators exert their effect can vary, depending on the structure and nature of the activating molecule, but in general, these compounds can modulate the protein's activity, which, in turn, affects the cellular processes it regulates.
The structure-activity relationship (SAR) of SPDYE2L activators is an area of keen interest because it enables the understanding of how different chemical modifications can influence the interaction between the activator and the SPDYE2L protein. By studying the SAR, researchers can design molecules that have higher potency, selectivity, and efficacy in modulating SPDYE2L. The chemical diversity of SPDYE2L activators can be vast, ranging from small organic molecules to larger biologically-based compounds. The development and characterization of these activators require an in-depth understanding of the protein's structure, the conformational dynamics of its active site, and how it interacts with various potential activators. Advances in techniques such as X-ray crystallography, NMR spectroscopy, and computational modeling play a crucial role in this endeavor, allowing for the visualization of molecular interactions at the atomic level and the rational design of new molecules capable of modulating the SPDYE2L protein's function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cAMP levels, which could enhance SPDYE2L activity via PKA activation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that increases cAMP levels, potentially enhancing SPDYE2L activity through PKA-mediated signaling pathways. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, increases cAMP levels, which may lead to enhanced SPDYE2L activity through PKA-driven pathways. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Activates G protein-coupled receptors that increase cAMP levels, potentially augmenting SPDYE2L activity via downstream effectors such as PKA. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Selective phosphodiesterase 4 inhibitor, raises cAMP levels, potentially enhancing SPDYE2L activity by PKA activation. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Phosphodiesterase 5 inhibitor, increases cAMP levels, which may indirectly enhance SPDYE2L activity via PKA signaling. | ||||||
Anagrelide | 68475-42-3 | sc-491875 | 25 mg | $150.00 | ||
Inhibits phosphodiesterase 3, raises cAMP levels, potentially resulting in enhanced SPDYE2L activity through PKA pathways. | ||||||
Milrinone | 78415-72-2 | sc-201193 sc-201193A | 10 mg 50 mg | $165.00 $697.00 | 7 | |
Phosphodiesterase 3 inhibitor, raises cAMP levels, which could enhance SPDYE2L activity via PKA-dependent mechanisms. | ||||||
Dipyridamole | 58-32-2 | sc-200717 sc-200717A | 1 g 5 g | $31.00 $102.00 | 1 | |
Inhibits phosphodiesterase enzymes and can increase cAMP levels, potentially enhancing SPDYE2L activity via PKA. | ||||||
Cilostazol | 73963-72-1 | sc-201182 sc-201182A | 10 mg 50 mg | $109.00 $322.00 | 3 | |
Inhibits phosphodiesterase 3, resulting in increased cAMP levels which may enhance SPDYE2L activity through PKA signaling. | ||||||